SomnoMed Limited (ASX:SOM)
Australia flag Australia · Delayed Price · Currency is AUD
0.7950
+0.0050 (0.63%)
Aug 29, 2025, 3:47 PM AEST

SomnoMed Statistics

Total Valuation

SomnoMed has a market cap or net worth of AUD 173.46 million. The enterprise value is 164.19 million.

Market Cap173.46M
Enterprise Value 164.19M

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date Aug 22, 2025
Ex-Dividend Date n/a

Share Statistics

SomnoMed has 218.18 million shares outstanding. The number of shares has increased by 75.64% in one year.

Current Share Class 218.18M
Shares Outstanding 218.18M
Shares Change (YoY) +75.64%
Shares Change (QoQ) +42.66%
Owned by Insiders (%) 7.84%
Owned by Institutions (%) 28.30%
Float 103.58M

Valuation Ratios

PE Ratio n/a
Forward PE 83.68
PS Ratio 1.56
PB Ratio 3.74
P/TBV Ratio 4.59
P/FCF Ratio 32.35
P/OCF Ratio 22.28
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.69, with an EV/FCF ratio of 30.62.

EV / Earnings -47.50
EV / Sales 1.47
EV / EBITDA 38.69
EV / EBIT n/a
EV / FCF 30.62

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.17.

Current Ratio 1.51
Quick Ratio 1.10
Debt / Equity 0.17
Debt / EBITDA 1.89
Debt / FCF 1.50
Interest Coverage -0.77

Financial Efficiency

Return on equity (ROE) is -7.56% and return on invested capital (ROIC) is -0.37%.

Return on Equity (ROE) -7.56%
Return on Assets (ROA) -0.26%
Return on Invested Capital (ROIC) -0.37%
Return on Capital Employed (ROCE) -0.59%
Revenue Per Employee 371,643
Profits Per Employee -11,521
Employee Count 300
Asset Turnover 1.48
Inventory Turnover 6.53

Taxes

In the past 12 months, SomnoMed has paid 2.69 million in taxes.

Income Tax 2.69M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +106.49% in the last 52 weeks. The beta is 0.99, so SomnoMed's price volatility has been similar to the market average.

Beta (5Y) 0.99
52-Week Price Change +106.49%
50-Day Moving Average 0.71
200-Day Moving Average 0.57
Relative Strength Index (RSI) 61.38
Average Volume (20 Days) 37,026

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SomnoMed had revenue of AUD 111.49 million and -3.46 million in losses. Loss per share was -0.02.

Revenue111.49M
Gross Profit 66.73M
Operating Income -311,010
Pretax Income -763,863
Net Income -3.46M
EBITDA 1.58M
EBIT -311,010
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 17.29 million in cash and 8.03 million in debt, giving a net cash position of 9.27 million or 0.04 per share.

Cash & Cash Equivalents 17.29M
Total Debt 8.03M
Net Cash 9.27M
Net Cash Per Share 0.04
Equity (Book Value) 46.39M
Book Value Per Share 0.21
Working Capital 14.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.78 million and capital expenditures -2.42 million, giving a free cash flow of 5.36 million.

Operating Cash Flow 7.78M
Capital Expenditures -2.42M
Free Cash Flow 5.36M
FCF Per Share 0.02
Full Cash Flow Statement

Margins

Gross margin is 59.85%, with operating and profit margins of -0.28% and -3.10%.

Gross Margin 59.85%
Operating Margin -0.28%
Pretax Margin -0.69%
Profit Margin -3.10%
EBITDA Margin 1.42%
EBIT Margin -0.28%
FCF Margin 4.81%

Dividends & Yields

SomnoMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -75.64%
Shareholder Yield n/a
Earnings Yield -1.99%
FCF Yield 3.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 27, 2009. It was a reverse split with a ratio of 0.05.

Last Split Date Nov 27, 2009
Split Type Reverse
Split Ratio 0.05

Scores

SomnoMed has an Altman Z-Score of 1.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.99
Piotroski F-Score 3